BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10946011)

  • 1. Kidney lipids in galactosylceramide synthase-deficient mice. Absence of galactosylsulfatide and compensatory increase in more polar sulfoglycolipids.
    Tadano-Aritomi K; Hikita T; Fujimoto H; Suzuki K; Motegi K; Ishizuka I
    J Lipid Res; 2000 Aug; 41(8):1237-43. PubMed ID: 10946011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
    Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
    BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.
    van der Bijl P; Strous GJ; Lopes-Cardozo M; Thomas-Oates J; van Meer G
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):589-97. PubMed ID: 8713090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase.
    Suzuki K; Vanier MT; Coetzee T; Popko B
    Neurochem Res; 1999 Apr; 24(4):471-4. PubMed ID: 10227678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic responses of sulfatide and related glycolipids in Madin-Darby canine kidney (MDCK) cells under osmotic stresses.
    Niimura Y; Nagai K
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Jan; 149(1):161-7. PubMed ID: 17905621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of sphingoglycolipids and sulfolipids in kidney cell lines under heat stress: activation of monohexosylceramide synthesis as a ceramide scavenger.
    Niimura Y; Moue T; Takahashi N; Nagai K
    Glycobiology; 2010 Jun; 20(6):710-7. PubMed ID: 20157020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of nine sulfated glycosphingolipids containing two unique sulfated gangliosides from the African green monkey kidney cells, Verots S3, and their possible metabolic pathways.
    Niimura Y; Ishizuka I
    Glycobiology; 2006 Aug; 16(8):729-35. PubMed ID: 16614164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal sulfoglycolipid storage in the kidneys of mice deficient for arylsulfatase A (ASA) and of double-knockout mice deficient for ASA and galactosylceramide synthase.
    Lüllmann-Rauch R; Matzner U; Franken S; Hartmann D; Gieselmann V
    Histochem Cell Biol; 2001 Aug; 116(2):161-9. PubMed ID: 11685544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of brefeldin A on galactosphingolipid synthesis in an immortalized Schwann cell line: evidence for different intracellular locations of galactosylceramide sulfotransferase and ceramide galactosyltransferase activities.
    Farrer RG; Warden MP; Quarles RH
    J Neurochem; 1995 Oct; 65(4):1865-73. PubMed ID: 7561886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
    Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
    J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divalent cation-mediated interaction between cerebroside sulfate and cerebrosides: an investigation of the effect of structural variations of lipids by electrospray ionization mass spectrometry.
    Koshy KM; Wang J; Boggs JM
    Biophys J; 1999 Jul; 77(1):306-18. PubMed ID: 10388759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
    Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
    Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.
    Okahara K; Kizuka Y; Kitazume S; Ota F; Nakajima K; Hirabayashi Y; Maekawa M; Yoshikawa T; Taniguchi N
    Glycobiology; 2014 Oct; 24(10):926-34. PubMed ID: 24821492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney sulfatides in mouse models of inherited glycosphingolipid disorders: determination by nano-electrospray ionization tandem mass spectrometry.
    Sandhoff R; Hepbildikler ST; Jennemann R; Geyer R; Gieselmann V; Proia RL; Wiegandt H; Grone HJ
    J Biol Chem; 2002 Jun; 277(23):20386-98. PubMed ID: 11919180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarity of neutral glycolipids, gangliosides, and sulfated lipids in MDCK epithelial cells.
    Nichols GE; Shiraishi T; Young WW
    J Lipid Res; 1988 Sep; 29(9):1205-13. PubMed ID: 3183526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of neutral glycosphingolipids in kidney slices from male and female mice.
    McCluer RH; Gross SK
    J Lipid Res; 1985 May; 26(5):593-9. PubMed ID: 4020297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve conduction velocity measurements reveal the functional deficit in ceramide galactosyl transferase-deficient (cgt-/-) mice.
    Haupt WF; Stoffel W
    J Neurol Sci; 2004 Jan; 217(1):83-8. PubMed ID: 14675614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.
    Saadat L; Dupree JL; Kilkus J; Han X; Traka M; Proia RL; Dawson G; Popko B
    Glia; 2010 Mar; 58(4):391-8. PubMed ID: 19705459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide.
    Ezoe T; Vanier MT; Oya Y; Popko B; Tohyama J; Matsuda J; Suzuki K; Suzuki K
    J Neurosci Res; 2000 Jan; 59(2):170-8. PubMed ID: 10650875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.